$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
What are the side effects of capmatinib and how to deal with them?
2025-10-19 11:44:20
Check Details
What is the efficacy of Vandetanib in treating lung cancer and thyroid cancer?
2025-10-19 11:44:20
Check Details
What are the efficacy, functions and side effects of Suvotinib?
2025-10-19 11:44:20
Check Details
Is lorlatinib useful for brain metastases?
2025-10-19 11:44:20
Check Details
What are the uses, efficacy and resistance time of the targeted drug lorlatinib?
2025-10-19 11:44:20
Check Details
What are the precautions and contraindications for Suvotinib?
2025-10-19 11:44:20
Check Details
What is the difference between Serpatinib and Platinib?
2025-10-19 11:44:20
Check Details
Should brigatinib or lorlatinib be used after alectinib resistance?
2025-10-19 11:44:20
Check Details
What are the side effects and treatment measures of rubitidine in treating lung cancer? _ Kanghule
2025-10-19 11:44:20
Check Details
Can aletinib cure tumors?
2025-10-19 11:44:20
Check Details
What is the effect of AMG510 on G12D mutation?
2025-10-19 11:44:20
Check Details
Which one is more effective, ceritinib or aletinib?
2025-10-19 11:44:20
Check Details
1
2
...
4124
4125
4126
4127
4128
4129
4130
...
4154
4155
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Garsorasib Clinical Updates and KRAS G12C Targeted Therapy Prospects
2
FDA Accelerates Approval of Zongertinib: Precision Medicine Advancement for HER2-Mutated NSCLC
3
Sotorasib (Lumakras®): The First KRAS Inhibitor Revolutionizing Non-Small Cell Lung Cancer Treatment
4
LONSURF® (Trifluridine/Tipiracil): Unveiling the Global R&D and Supply Chain Behind the Oral Chemotherapy
5
FDA Approves Lilly's Inluriyo (Imlunestrant) for ESR1-Mutant Advanced Breast Cancer
6
Tivozanib: The Evolution of Highly Selective VEGFR Inhibition in Renal Cell Carcinoma
7
Trifluridine/Tipiracil: Managing Side Effects in Metastatic Colorectal and Gastric Cancer
8
Adagrasib Medication Management Guide for Special Populations
9
Olutasidenib (Rezlidhia): A Targeted Drug for IDH1-Mutated Relapsed/Refractory AML
10
Capmatinib Redefines Precision Therapy for MET-Mutated Lung Cancer
11
Cabozantinib: Pivotal Advancements and Global Implications in Multi-Cancer Treatment with Multi-Kinase Inhibition
12
Tucatinib (Tukysa): A Precision Medicine for HER2-Positive Breast & Colorectal Cancer